211 related articles for article (PubMed ID: 7978533)
1. Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts.
Portnoy J; Bagstad K; Kanarek H; Pacheco F; Hall B; Barnes C
Ann Allergy; 1994 Nov; 73(5):409-18. PubMed ID: 7978533
[TBL] [Abstract][Full Text] [Related]
2. Safety of rush immunotherapy to multiple aeroallergens in an adult population.
Harvey SM; Laurie S; Hilton K; Khan DA
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):414-9. PubMed ID: 15104192
[TBL] [Abstract][Full Text] [Related]
3. Accelerated immunotherapy schedules: review of efficacy and safety.
Cox L
Ann Allergy Asthma Immunol; 2006 Aug; 97(2):126-37; quiz 137-40, 202. PubMed ID: 16937741
[TBL] [Abstract][Full Text] [Related]
4. Nonfatal systemic allergic reactions induced by skin testing and immunotherapy.
Lin MS; Tanner E; Lynn J; Friday GA
Ann Allergy; 1993 Dec; 71(6):557-62. PubMed ID: 8267250
[TBL] [Abstract][Full Text] [Related]
5. A 1-day imported fire ant rush immunotherapy schedule with and without premedication.
Arseneau AM; Nesselroad TD; Dietrich JJ; Moore LM; Nguyen S; Hagan LL; Tankersley MS
Ann Allergy Asthma Immunol; 2013 Dec; 111(6):562-6. PubMed ID: 24267369
[TBL] [Abstract][Full Text] [Related]
6. Incidence of systemic reactions during rush immunotherapy.
Portnoy J; King K; Kanarek H; Horner S
Ann Allergy; 1992 Jun; 68(6):493-8. PubMed ID: 1610025
[TBL] [Abstract][Full Text] [Related]
7. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
8. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus.
Tabar AI; Echechipía S; García BE; Olaguibel JM; Lizaso MT; Gómez B; Aldunate MT; Martin S; Marcotegui F
J Allergy Clin Immunol; 2005 Jul; 116(1):109-18. PubMed ID: 15990782
[TBL] [Abstract][Full Text] [Related]
9. Premedication with antihistamines may enhance efficacy of specific-allergen immunotherapy.
Müller U; Hari Y; Berchtold E
J Allergy Clin Immunol; 2001 Jan; 107(1):81-6. PubMed ID: 11149995
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
[TBL] [Abstract][Full Text] [Related]
11. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract.
Enrique E; Pineda F; Malek T; Bartra J; Basagaña M; Tella R; Castelló JV; Alonso R; de Mateo JA; Cerdá-Trias T; San Miguel-Moncín Mdel M; Monzón S; García M; Palacios R; Cisteró-Bahíma A
J Allergy Clin Immunol; 2005 Nov; 116(5):1073-9. PubMed ID: 16275379
[TBL] [Abstract][Full Text] [Related]
12. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
13. Rush immunotherapy: experience with a one-day schedule.
Sharkey P; Portnoy J
Ann Allergy Asthma Immunol; 1996 Feb; 76(2):175-80. PubMed ID: 8595538
[TBL] [Abstract][Full Text] [Related]
14. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
15. Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study.
Confino-Cohen R; Goldberg A
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):73-8. PubMed ID: 20143649
[TBL] [Abstract][Full Text] [Related]
16. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts.
Casanovas M; Martín R; Jiménez C; Caballero R; Fernández-Caldas E
Int Arch Allergy Immunol; 2006; 139(2):153-8. PubMed ID: 16374026
[TBL] [Abstract][Full Text] [Related]
17. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study.
Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W
Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
20. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction.
Kelso JM
Ann Allergy Asthma Immunol; 2004 Feb; 92(2):225-7. PubMed ID: 14989390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
